{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:37:49Z","timestamp":1787071069567,"version":"build-2736575974"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:p>Stewart\u2013Treves syndrome (STS) is a rare, cutaneous angiosarcoma associated with chronic lymphedema. The prognosis of this syndrome is extremely poor, with a median survival time of 5\u20138 months, if untreated. An 82-year-old Asian woman noticed a painless elastic mass with partial discoloration (purplish discoloration) on the left thigh. She had lower lymphedema for 15 years. Lesion biopsy and immunohistochemistry analysis led to the diagnosis of angiosarcoma, which was considered to be STS. She was referred to our department for concurrent chemoradiotherapy. Radiation therapy consisted of 25 daily fractions of 2 Gy each (prescription dose: 50 Gy). Concurrent chemotherapy consisted of 2 monthly cycles of docetaxel (75 mg\/body on day 1) and recombinant interleukin-2 (700,000 units\/body on days 1\u20135). She experienced acute adverse events such as Grade 2 dermatitis, Grade 2 anemia, and Grade 4 leukopenia. Posttreatment computed tomography images revealed that lesions had disappeared. Moreover, the accumulation patterns on positron emission tomography images were markedly weakened after the treatment. She exhibited no signs of recurrence for 4 years.<\/jats:p>","DOI":"10.4103\/jcrt.jcrt_215_21","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T02:38:43Z","timestamp":1644892723000},"page":"840-842","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Remarkable response to radiation therapy with concurrent chemotherapy in Stewart\u2013Treves syndrome"],"prefix":"10.4103","volume":"18","author":[{"given":"Atsuto","family":"Katano","sequence":"first","affiliation":[{"name":"Department of Radiology, The University of Tokyo Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideomi","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Radiology, The University of Tokyo Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,2,15]]},"reference":[{"key":"R1-20250514","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/1097-0142(194805)1:1<64::AID-CNCR2820010105>3.0.CO;2-W","article-title":"Lymphangiosarcoma in postmastectomy lymphedema; A report of six cases in elephantiasis chirurgica","volume":"1","author":"Stewart","year":"1948","journal-title":"Cancer"},{"key":"R2-20250514","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1159\/000506975","article-title":"IL-23 Expression in Stewart-Treves syndrome: Two case reports and immunohistochemical investigation","volume":"13","author":"Yoshida","year":"2020","journal-title":"Case Rep Oncol"},{"key":"R3-20250514","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.lpm.2010.06.017","article-title":"Stewart-Treves syndrome (angiosarcoma on lyphoedema): A rare complication of lymphoedema","volume":"39","author":"Wierzbicka-Hainaut","year":"2010","journal-title":"Presse Med"},{"key":"R4-20250514","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.jaad.2012.04.028","article-title":"Stewart-Treves syndrome: Pathogenesis and management","volume":"67","author":"Sharma","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"R5-20250514","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S1470-2045(10)70023-1","article-title":"Angiosarcoma","volume":"11","author":"Young","year":"2010","journal-title":"Lancet Oncol"},{"key":"R6-20250514","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.ijrobp.2004.08.008","article-title":"Angiosarcoma of the scalp treated with curative radiotherapy plus recombinant interleukin-2 immunotherapy","volume":"61","author":"Ohguri","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R7-20250514","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1200\/JCO.2008.17.3146","article-title":"Phase II trial of weekly paclitaxel for unresectable angiosarcoma: The ANGIOTAX Study","volume":"26","author":"Penel","year":"2008","journal-title":"J Clin Oncol"},{"key":"R8-20250514","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/0284186X.2016.1234068","article-title":"Pazopanib in advanced vascular sarcomas: An EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis","volume":"56","author":"Koll\u00e1r","year":"2017","journal-title":"Acta Oncol"},{"key":"R9-20250514","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/bjd.19042","article-title":"The efficacy of eribulin mesylate for patients with cutaneous angiosarcoma previously treated with taxane: A multicentre prospective observational study","volume":"183","author":"Fujisawa","year":"2020","journal-title":"Br J Dermatol"},{"key":"R10-20250514","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1200\/JCO.2012.41.8574","article-title":"Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: A review","volume":"30","author":"Paskett","year":"2012","journal-title":"J Clin Oncol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_215_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:41:03Z","timestamp":1787067663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_215_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,15]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_215_21","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,15]]},"assertion":[{"value":"2021-02-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}